Collaborative Fund Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Collaborative Fund Advisors's RPRX Position: Q3 2026 in Review
Collaborative Fund Advisors sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 9,331 shares — an estimated $523K sold.
Collaborative Fund Advisors first reported a position in RPRX in Q1 2026 and held it in 2 quarters. The position peaked at $724K in Q1 2026. 703 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Collaborative Fund Advisors reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
- Collaborative Fund Advisors sold 9,331 Royalty Pharma shares in Q3 2026, an estimated $523K.
- Collaborative Fund Advisors first reported a position in Royalty Pharma in Q1 2026 and held it in 2 quarters.
- Collaborative Fund Advisors's Royalty Pharma position peaked at $724K in Q1 2026.
- 703 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Collaborative Fund Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.